SDS Biotech K.K. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Year Ending December 31, 2014
SDS Biotech K.K. announced consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were ¥3,673 million compared with ¥2,513 million a year ago. Operating income was ¥405 million compared with ¥191 million a year ago. Ordinary income was ¥338 million compared with ¥186 million a year ago. Net income was ¥210 million or ¥26.83 per diluted share compared with ¥123 million or ¥15.80 per diluted share a year ago. As on March 31, 2014, the company's net assets per share was ¥626.00. Net income before taxes for the quarter was ¥338.8 million compared with ¥185.8 million a year ago.
For the year ending December 31, 2014, the company forecasts net sales of ¥14,866 million, operating income of ¥1,352 million, ordinary income of ¥1,179 million, net income of ¥684 million or ¥87.35.